DK321676A - - Google Patents

Info

Publication number
DK321676A
DK321676A DK321676A DK321676A DK321676A DK 321676 A DK321676 A DK 321676A DK 321676 A DK321676 A DK 321676A DK 321676 A DK321676 A DK 321676A DK 321676 A DK321676 A DK 321676A
Authority
DK
Denmark
Application number
DK321676A
Other versions
DK142877C (da
DK142877B (da
Inventor
A F Marx
N C M E Barendse
Original Assignee
Gist-Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist-Brocades Nv filed Critical Gist-Brocades Nv
Publication of DK321676A publication Critical patent/DK321676A/da
Publication of DK142877B publication Critical patent/DK142877B/da
Application granted granted Critical
Publication of DK142877C publication Critical patent/DK142877C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0053 membered carbocyclic rings in position 12
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0073 membered carbocyclic rings in position 6-7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK321676AA 1975-07-16 1976-07-15 Analogifremgangsmåde til fremstilling af 16-dehydro-androstan-derivater. DK142877B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB29898/75A GB1550343A (en) 1975-07-16 1975-07-16 Androstane derivatives
GB2989875 1975-07-16

Publications (3)

Publication Number Publication Date
DK321676A true DK321676A (da) 1977-01-17
DK142877B DK142877B (da) 1981-02-16
DK142877C DK142877C (da) 1981-09-28

Family

ID=10298992

Family Applications (1)

Application Number Title Priority Date Filing Date
DK321676AA DK142877B (da) 1975-07-16 1976-07-15 Analogifremgangsmåde til fremstilling af 16-dehydro-androstan-derivater.

Country Status (20)

Country Link
US (1) US4075233A (da)
JP (1) JPS5212159A (da)
AT (1) AT362085B (da)
AU (1) AU506101B2 (da)
BE (1) BE844169A (da)
CH (1) CH626379A5 (da)
DE (1) DE2631915A1 (da)
DK (1) DK142877B (da)
FI (1) FI55851C (da)
FR (1) FR2317934A1 (da)
GB (1) GB1550343A (da)
HU (1) HU175369B (da)
IE (1) IE43693B1 (da)
IT (1) IT1063150B (da)
LU (1) LU75394A1 (da)
NL (1) NL7607824A (da)
NO (1) NO146865C (da)
NZ (1) NZ181482A (da)
SE (1) SE7608092L (da)
ZA (1) ZA764195B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1566905A (en) * 1977-03-28 1980-05-08 Gist Brocades Nv Steroids of the a-nor-androstane and a-nor-estrane series
DE3115995A1 (de) * 1981-04-13 1982-11-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen D-homo-4,17-androstadien-3-on, verfahren zu seiner herstellung und diese verbindung enthaltende pharmazeutische praeparate
JPS58185406A (ja) * 1982-04-20 1983-10-29 Mitsubishi Gas Chem Co Inc 過硼酸塩の製造方法
CA1314870C (en) * 1983-08-02 1993-03-23 Arthur G. Schwartz Steroids useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents
DE3514272A1 (de) * 1985-04-17 1986-10-23 Schering AG, 1000 Berlin und 4709 Bergkamen Dermatica
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US5028631A (en) * 1987-11-25 1991-07-02 Schwartz Arthur G Homoandrostan-17-one and homoandrosten-17-ones
US5001119A (en) * 1987-11-25 1991-03-19 Schwartz Arthur G 16-substituted androstanes and 16-substituted androstenes
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
US5925774A (en) * 1991-01-07 1999-07-20 Pherin Corporation Estrenes for inducing hypothalamic effects
US5883087A (en) * 1991-01-07 1999-03-16 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
WO1994028904A1 (en) * 1993-06-15 1994-12-22 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6331534B1 (en) 1994-08-04 2001-12-18 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to alleviate pain
US6066627A (en) * 1994-08-04 2000-05-23 Pherin Corporation Steroids as neurochemical initiators of change in human blood levels of LH
US6057439A (en) * 1994-08-04 2000-05-02 Pherin Corporation Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US6117860A (en) * 1994-08-04 2000-09-12 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia
CN112778390B (zh) * 2021-01-22 2022-09-30 厦门欧瑞捷生物科技有限公司 一种雄烯酮的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3501462A (en) * 1966-05-02 1970-03-17 Sterling Drug Inc 17-cyclopropyl steroids

Also Published As

Publication number Publication date
NO762483L (da) 1977-01-18
DK142877C (da) 1981-09-28
IE43693L (en) 1977-01-16
IT1063150B (it) 1985-02-11
FR2317934B1 (da) 1980-11-07
BE844169A (fr) 1977-01-17
DE2631915A1 (de) 1977-02-03
JPS5212159A (en) 1977-01-29
AT362085B (de) 1981-04-27
GB1550343A (en) 1979-08-15
FI55851C (fi) 1979-10-10
HU175369B (hu) 1980-07-28
AU1593876A (en) 1978-01-19
US4075233A (en) 1978-02-21
NO146865C (no) 1982-12-22
FI55851B (fi) 1979-06-29
AU506101B2 (en) 1979-12-13
SE7608092L (sv) 1977-01-17
IE43693B1 (en) 1981-05-06
ATA519776A (de) 1980-09-15
ZA764195B (en) 1977-07-27
NL7607824A (nl) 1977-01-18
NZ181482A (en) 1978-12-18
FI762058A (da) 1977-01-17
CH626379A5 (da) 1981-11-13
FR2317934A1 (fr) 1977-02-11
LU75394A1 (da) 1977-02-28
DK142877B (da) 1981-02-16
NO146865B (no) 1982-09-13

Similar Documents

Publication Publication Date Title
JPS541624B2 (da)
DK142877C (da)
JPS5331664B2 (da)
JPS5546988B2 (da)
JPS5230579U (da)
JPS5339258B2 (da)
JPS5266031U (da)
JPS5329408Y2 (da)
JPS5435845Y2 (da)
JPS5219519U (da)
JPS51156839U (da)
JPS51154493U (da)
JPS5222035U (da)
JPS51133069U (da)
CH597391A5 (da)
CH596884A5 (da)
CH595232A5 (da)
CH594898A5 (da)
CH594807A5 (da)
CH594604A5 (da)
CH595661A5 (da)
CH594270A5 (da)
CH593593A5 (da)
CH592772B5 (da)
CH592437A5 (da)